FDA Import Refusal SCS-2118012-5/12/1 — NAD+ AT HOME

NAD+ AT HOME — FEI 3029515333

The FDA refused shipment SCS-2118012-5/12/1 from NAD+ AT HOME (United Kingdom) on Jul 31, 2025. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 3 other import refusals on record.